EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

The Effect of Different Statin‐Based Lipid‐Lowering Strategies on C‐Reactive Protein Levels in Patients With Stable Coronary Artery Disease

Zhimin Xue, Miao Ye, Hangpan Jiang, Duanbin Li, Xulin Hong, Zhezhe Chen, Ya Li, Binquan Zhou, Wenbin Zhang, Miaoyun Wang

Clinical Cardiology · 2024

DOI: 10.1002/clc.24301 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Zhimin Xue und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, C-Reactive Protein, Coronary Artery Disease, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Traditional Chinese Medicine Science and Technology Project of Zhejiang Province, Medical Health Science and Technology Project of Zhejiang Provincial Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Statins are lipid‐lowering drugs with favorable anti‐inflammatory effects. This study aimed to explore different statin‐based lipid‐lowering strategies to reduce high‐sensitivity C‐reactive protein (hs‐CRP). Hypothesis The hypothesis is that different statin‐based lipid‐lowering strategies might reduce hs‐CRP.

Methods

This retrospective study included 3653 patients who underwent percutaneous coronary intervention (PCI). Three statin‐based lipid‐lowering strategies were investigated, including different types of statins (atorvastatin vs. rosuvastatin), statin combined with ezetimibe therapy (vs. without), and intensive statin therapy (vs. regular). The hs‐CRP levels and blood lipid indicators were measured at baseline and after 1‐month lipid‐lowering therapy. Multivariable linear regression analysis and structural equation mode analysis were conducted to verify the association between different lipid‐lowering strategies, Δhs‐CRP (%) and ΔLDL‐C (%).

Results

Totally, 3653 patients were enrolled with an average age of 63.81 years. Multivariable linear regression demonstrated that statin combined with ezetimibe therapy was significantly associated with decreased Δhs‐CRP (%) ( β = −0.253, 95% CI: [−0.501 to −0.005], p = 0.045). The increased ΔLDL‐C (%) was an independent predictor of elevated levels of Δhs‐CRP (%) ( β = 0.487, 95% CI: [0.15−0.824], p = 0.005). Furthermore, structural equation model analysis proved that statin combined with ezetimibe therapy ( β = −0.300, p < 0.001) and intensive statin therapy ( β = −0.032, p = 0.043) had an indirect negative effect on Δhs‐CRP via ΔLDL‐C.

Conclusions

Compared with routine statin use, statin combined with ezetimibe therapy and intensive statin therapy could further reduce hs‐CRP levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsC-Reactive ProteinCoronary Artery DiseaseBiomarkersPercutaneous Coronary InterventionEzetimibeHumansMaleRetrospective StudiesFemaleMiddle AgedTreatment OutcomeDrug Therapy, CombinationAgedRosuvastatin CalciumAtorvastatinCholesterol, LDLAnticholesteremic AgentsDyslipidemias

Stichwörter der Autor:innen

ezetimibeinflammationlipid‐lowering therapystable coronary artery diseasestatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsC-Reactive ProteinBiomarkersEzetimibeRosuvastatin CalciumAtorvastatinCholesterol, LDLAnticholesteremic Agents

Autor:innen und Institutionen

  • Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.
  • Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Zhejiang, Hangzhou, China.
  • Department of Cardiology, The Fourth Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.
  • Hangzhou Medical College Affiliated Lin An People's Hospital, Hangzhou, China.

Förderung

  • Traditional Chinese Medicine Science and Technology Project of Zhejiang Province
  • Medical Health Science and Technology Project of Zhejiang Provincial Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Xue, Z., Ye, M., Jiang, H., Li, D., Hong, X., Chen, Z., Li, Y., Zhou, B., Zhang, W., & Wang, M. (2024). The Effect of Different Statin‐Based Lipid‐Lowering Strategies on C‐Reactive Protein Levels in Patients With Stable Coronary Artery Disease. Clinical Cardiology. https://doi.org/10.1002/clc.24301

Vancouver

Xue Z, Ye M, Jiang H, Li D, Hong X, Chen Z, et al. The Effect of Different Statin‐Based Lipid‐Lowering Strategies on C‐Reactive Protein Levels in Patients With Stable Coronary Artery Disease. Clinical Cardiology. 2024. doi:10.1002/clc.24301

BibTeX
@article{Xue2024,
  author = {Xue, Zhimin and Ye, Miao and Jiang, Hangpan and Li, Duanbin and Hong, Xulin and Chen, Zhezhe and Li, Ya and Zhou, Binquan and Zhang, Wenbin and Wang, Miaoyun},
  title = {The Effect of Different Statin‐Based Lipid‐Lowering Strategies on C‐Reactive Protein Levels in Patients With Stable Coronary Artery Disease},
  journal = {Clinical Cardiology},
  year = {2024},
  doi = {10.1002/clc.24301}
}
Kostenlos starten →